About Divis Laboratories Ltd
Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generics, the Company, through its custom synthesis, supports innovator pharma
Founded
1990
CEO
Ramesh B V Nimmagadda
Employees
19,292
HQ
Hyderabad, India
Finished Products
1Sale of Products
₹42,172.00Cr2Sale of Services
₹317.77Cr3Sale of Scrap
₹272.08Cr4Export incentives
₹167.58CrRaw Materials
1Raw Material Consumed
₹6,709.79Cr2Packing Material
₹59.39CrAbout Divis Laboratories Ltd
Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generics, the Company, through its custom synthesis, supports innovator pharma
Founded:1990
CEO:Ramesh B V Nimmagadda
Employees:19,292
HQ:Hyderabad, India
Finished Products
1Sale of Products
₹42,172.00Cr2Sale of Services
₹317.77Cr3Sale of Scrap
₹272.08Cr4Export incentives
₹167.58CrRaw Materials
1Raw Material Consumed
₹6,709.79Cr2Packing Material
₹59.39CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹9,467
52W Low
₹5,637
Volume403.62K
Avg VolumeN/A
Beta0.60
Dividend Yield0.32%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
83.79x
Valuation
P/B Ratio
14.62x
Valuation
EPS
₹110.18
Valuation
Dividend Yield
0.32%
Valuation
ROE
15.32%
Profitability
ROCE
19.56%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacture of Active PharmaceuticaRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
11.0%
International
89.0%
Europe61.0%
America13.2%
India11.0%
Asia10.2%
Rest of the world4.5%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
10.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.